Abstract
The influence of the antitumor drugs, cyclophosphamide (CPA) and nitrosomethylurea (NMU) on the activity of lysosomal cysteine proteases cathepsin B and L in tumor tissue has been investigated using CPA-sensitive (LS) and CPA-resistant mouse lymphosarcomas (RLS). (These drugs exhibit high and low antitumor efficiency towards LS and RLS mouse lymphosarcomas, respectively). Regression or reduction in the growth rate of LS and RLS lymphosarcomas caused by CPA or NMU administration was accompanied by the increase in the activity of cysteine proteases cathepsin B and L in the tumor tissue. The increase of cathepsin B and L activity in tumor tissue correlated with the therapeutic effect of these drugs. Data obtained suggest that activity of cathepsin B and L in tumor tissue has a prognostic significance for the estimation of the effectiveness of antitumor therapy.
Similar content being viewed by others
References
Dickinson, D.P., Crit. Rev. Oral. Biol., 2002, vol. 13, pp. 238–275.
DeClerck, Y.A., Mercurio, A.M., Stack, M.S., Chapman, H.A., Zutter, M.M., Muschel, R.J., Raz, A., Matrisian, L.M., Sloane, B.F., Noel, A., Hendrix, M.J., Coussens, L., and Padarathingh, M., Am. J. Physiol., 2004, vol. 164, pp. 1131–1139.
Van Hinsbergh, V.W.M., Engelse, M.A., and Quax, P.H.A., J. Am. Heart Association, 2006, vol. 26, pp. 716–728.
Buck, M.R., Karustis, D.G., Day, N.A., Honn, K.V., and Sloane, B.F., Biochem. J., 1992, vol. 282, pp. 273–277.
Kos, J., Werle, B., Lah, T., and Brunner, N., Int. J. Biol. Marker, 2000, vol. 15, pp. 84–89.
Ravanko, K., Järvinen, K., Helin, J., Kalkkinen, N., and Hölttä, E., Cancer Res., 2004, vol. 64, pp. 8831–8838.
Stoka, V., Turk, B., and Turk, V., IUBMB Life, 2005, vol. 57, pp. 347–353.
Buhling, F., Waldburg, N., Reisenauer, A., Heimburg, A., Golpon, H., and Welte, T., Eur. Respir. J., 2004, vol. 23, pp. 620–628.
Tobin, D.J., Foitzik, K., Reinheckel, T., Mecklenburg, L., Botchkarev, V.A., Peters, C., and Paus, R., Am. J. Pathol., 2002, vol. 160, pp. 1807–1821.
Guo, M., Mathieu, P.A., Linebaugh, B., Sloane, B.F., and Reiner, J.J., J. Biol. Chem., 2002, vol. 277, pp. 14829–14837.
Lah, T.T., Cercek, M., Blejek, A., Kos, J., Gorodetsky, E., Somers, R., and Daskal, I., Clin. Cancer Res., 2000, vol. 6, pp. 578–584.
Ledakis, P., Tester, W.T., Rosenberg, N., Romero-Fischmann, D., Daskal, I., and Lah, T.T., Clin Cancer Res., 1996, vol. 2, pp. 561–568.
Hazen, L.G.M., Bleeker, F.E., Lauritzen, B., Bahns, S., Song, J., Jonker, A., van Driel, B.E.M., Lyon, H., Hansen, U., Kohler, A., and van Noorden, C.J.F., J. Histochem. Cytochem., 2000, vol. 48, pp. 1421–1430.
Strojan, P., Budihna, M., Smid, L., Svetic, B., Vrhovec, I., Kos, J., and Skrk, J., Clin. Cancer Res., 2000, vol. 6, pp. 1052–1062.
Rozhin, J., Gomez, A.P., Ziegler, G.H., Nelson, K.K., Chang, Y.S., Fong, D., Onoda, J.M., Honn, K.V., and Sloane, B.F., Cancer Res., 1990, vol. 50, pp. 6278–6284.
Szpaderska, A.M. and Frankfater, A., Cancer Res., 2001, vol. 61, pp. 3493–3500.
Vasiljeva, O., Papazoglou, A., Kruger, A., Brodoefel, H., Korovin, M., Deussing, J., Augustin, N., Nielsen, B.S., Almholt, K., Bogyo, M., Peters, C., and Reinheckell, T., Cancer Res., 2006, vol. 66, pp. 5242–5250.
Shehan, K., Shuja, S., and Murnane, M., Cancer Res., 1989, vol. 49, pp. 3809–3814.
Mehtani, S., Gong, Q., Panella, J., Subbiah, S., Peffley, D.M., and Frankfater, A., J. Biol. Chem., 1998, vol. 273, pp. 13236–13244.
Fehrenbacher, N. and Jäättelä, M., Cancer Res., 2005, vol. 65, pp. 2993–2995.
Ostenfeld, M.S., Fehrenbacher, N., Hoyer-Hansen, M., Thomsen, C., Farkas, T., and Jäättelä, M., Cancer Res., 2005, vol. 65, pp. 8975–8983.
Bröker, L.E., Huisman, C., Span, S.W., Rodriguez, J.A., Kruyt, A.E., and Giaccone, G., Cancer Res., 2004, vol. 64, pp. 27–30.
Nikolin, V.P., Kaledin, V.I., Baymak, T.Yu., Galyamova, M.R., Popova, N.A., and Voinitskii, V.E., Vopr. Onkol., 2002, vol. 48, pp. 211–215.
Barrett, A.J. and Kirschke, H., Methods Enzymol., 1981, vol. 80, pp. 535–561.
Zhanaeva, S.Ya., Korolenko, T.A., Khostchenko, O.M., Spiridonov, V.K., Nikolin, V.P., and Kaledin, V.I., Byull. Eksper. Biol. Med., 2005, no. 5, pp. 153–156.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © S.Ya. Zhanaeva, A.I. Dyakov, T.A. Alekseenko, T.A. Korolenko, 2009, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Zhanaeva, S.Y., Dyakov, A.I., Alekseenko, T.A. et al. Prognostic significance of lysosomal cysteine proteases in the estimation of the effectiveness of the antitumor therapy. Biochem. Moscow Suppl. Ser. B 3, 84–88 (2009). https://doi.org/10.1134/S1990750809010120
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750809010120